Clinical trial

Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and…

NCT00084344 · Northwestern University, Other · Completed

Key facts

NCT number NCT00084344
Title Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women
Official title A Prospective, Randomized, Placebo-Controlled Trial of the Effects of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women
Lead sponsor Northwestern University, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Interventional
Conditions Breast Cancer
Intervention type Drug, Procedure
Interventions 4-hydroxytamoxifen, breast imaging study, radiomammography
Start date Apr 1, 2003
Primary completion Jul 1, 2004
Completion Jul 1, 2004
First posted Jun 11, 2004
Last update posted May 30, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies